| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Oliphant Laura serves as a Director at AEHR. Across recent SEC filings that breaks down to 0 buys and 14 sells. Those positions are worth an estimated $2.1M at current prices.
Historically, Oliphant Laura's trades have earned a middling insider score of 56/100 across 14 rated trades. Over a 12-month horizon, 58.3% of those trades were profitable, with an average 12-month return of -11.6%.
The biggest single holding is AEHR (~$2.1M) as Director. The recent filings there lean toward selling, a net 98,009 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 28, 2021 | AEHR Aehr Test Systems | Director | Sell | 11,381 | $21.50 | $244,691.50 | -35.1% | -45.8% | -1.0% | |
| Aug 17, 2021 | AEHR Aehr Test Systems | Director | Sale+OE | 25,000 | $5.30 | $132,540.00 | -100% | +373.6% | +218.3% | |
| Jul 21, 2021 | AEHR Aehr Test Systems | Director | Sell | 18,456 | $5.75 | $106,122.00 | -37.8% | +147.2% | +51.2% |